Editors guide the peer review process and ensure that published research meets JTC standards for methodological rigor and thyroid oncology relevance.

Editors are expected to provide timely decisions, manage reviewer selection, and uphold ethical standards.

• Conduct initial scope and ethics screening
• Select reviewers with thyroid cancer expertise
• Evaluate reviewer comments and decision recommendations
• Ensure reporting standards and data transparency compliance
• Communicate clear revision guidance to authors

• Use standardized decision letters
• Encourage adherence to CONSORT, STROBE, or PRISMA
• Flag potential conflicts of interest
• Escalate integrity concerns promptly
• Promote data availability and reproducibility
• Encourage consistent decision letters and clear revision guidance.
• Ensure reviewer expertise matches thyroid cancer subtopics.
• Confirm ethics approvals and patient consent documentation.
• Monitor turnaround times and communicate delays promptly.
• Promote data transparency and reproducibility statements.
• Document conflicts of interest and recuse when needed.
• Coordinate with guest editors to align on scope fit.
• Verify clinical trial registration and reporting quality.
• Ensure statistical review for complex molecular studies.
• Request data access statements for sensitive clinical datasets.
• Encourage adherence to CONSORT, STROBE, PRISMA, or CARE.
• Check that imaging and pathology reporting are adequate.
• Ensure conclusions align with data and avoid overstatement.

JTC is committed to rigorous, transparent publishing in thyroid cancer research and care. We emphasize reproducible clinical methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in endocrine oncology, surgical outcomes, and translational thyroid research.